Chief Scientific Officer (1) · Kymera Therapeutics, Inc. (KYMR)

Richard Chesworth

FY2020 is the first fiscal year CompBrief holds for Richard Chesworth as a named executive officer of Kymera Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$4,534,243

Salary $144,946Stock awards $0

1st of 3 named executive officers at Kymera Therapeutics by FY2020 total.

3 named officers on file for Kymera Therapeutics, FY2020

Richard Chesworth’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • KYMR’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Kymera Therapeutics’s whole pay program stands against its peers

  • Kymera Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on KYMR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2021 (DEF 14A).

Free

Get Richard Chesworth’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Richard Chesworth compensation by year

Kymera Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Kymera Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$144,946
Bonus$0
Stock awards$0
Option awards$4,329,297
Non-equity incentive$60,000
Pension and deferred compensation$0
All other$0
Total$4,534,243

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Kymera Therapeutics, Inc. DEF 14A filed April 30, 2021, accession 0001193125-21-142735, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Kymera Therapeutics, Inc. filed document, accession 0001193125-21-142735. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2021.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option351,119—$20.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Kymera Therapeutics, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Kymera Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Richard Chesworth · this pageChief Scientific Officer (1)$4,534,243
Nello MainolfiFounder, President and Chief Executive Officer$3,678,001
Jared GollobChief Medical Officer$1,452,716

The full Kymera Therapeutics compensation record

free company brief

This page is one person within Kymera Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Kymera Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Kymera Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard Chesworth's compensation dossier · One-time report. No refunds.